Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerEdward H. Romond, Norman Wolmark|New England Journal of Medicine|2005Cited by 5.3k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisPatricia Cortazar, Gϋnter von Minckwitz, Luca Gianni et al.|The Lancet|2014Cited by 4.7k
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET TrialStephen Johnston, Samuel A. Jacobs, Shannon Puhalla et al.|Journal of Clinical Oncology|2018Cited by 233
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger, Daniel G. Stover, Katharine A. Collier et al.|npj Breast Cancer|2021Cited by 37